CARBIZOLE 10 Caibimazole (10mg) Carbimazole is a medication used to treat hyperthyroidism, a condition where the thyroid gland produces an excessive amount of thyroid hormones. Carbimazole is commonly used in Europe, while its active metabolite, methimazole, is more commonly used in the United States for the same purpose. Here are some key points about carbimazole: Mechanism of Action: Carbimazole works by inhibiting the production of thyroid hormones in the thyroid gland. It interferes with the conversion of iodine into thyroid hormones, thereby reducing the levels of thyroid hormones in the bloodstream. Indications: Carbimazole is primarily used to treat hyperthyroidism, which can be caused by conditions such as Graves' disease or toxic multinodular goiter. By lowering thyroid hormone levels, it helps alleviate symptoms associated with hyperthyroidism, such as rapid heart rate, weight loss, tremors, and anxiety. Dosage: The dosage of carbimazole can vary depending on the severity of hyperthyroidism and individual patient factors. Treatment typically starts with a higher dose to quickly control hyperthyroidism, followed by a lower maintenance dose to keep thyroid hormone levels within a normal range. Monitoring: Patients taking carbimazole are regularly monitored by healthcare providers to assess thyroid function and adjust the medication dosage as needed. Blood tests, including thyroid function tests, are typically used to gauge treatment effectiveness. Side Effects: Common side effects of carbimazole may include skin rash, itching, nausea, and a metallic taste in the mouth. Some patients may experience more severe side effects, such as liver problems or a drop in white blood cell count. Patients should report any unusual or severe symptoms to their healthcare provider. Treatment Duration: The duration of carbimazole treatment depends on the underlying cause of hyperthyroidism and the patient's response to the medication. Some individuals may require treatment for several months or even years, while others may eventually undergo other therapies like radioactive iodine treatment or surgery. Pregnancy and Breastfeeding: Carbimazole is generally not recommended during pregnancy due to potential harm to the developing fetus. Pregnant women with hyperthyroidism are often transitioned to another treatment option like propylthiouracil (PTU), which is considered safer during pregnancy. Carbimazole is also not recommended while breastfeeding. It's important for individuals with hyperthyroidism to work closely with their healthcare provider, who can determine the appropriate treatment plan, monitor thyroid function, and manage any potential side effects or complications. Treatment for hyperthyroidism is typically tailored to the individual's specific condition and needs. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/carbizole-10-133891